Collaboration for Lung Cancer Research
Organizations join forces to fund research on the effects of air pollution and climate change in lung cancer.
The Lung Cancer Research Foundation (LCRF) and Oncology Advocates United for Climate and Health – International (OUCH-I) are partnering to fund innovative projects aimed at understanding how environmental pollution and climate change influence lung cancer risks, diagnoses, treatment options, and patient outcomes. This collaborative effort is titled OUCH-International and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and Lung Cancer Prevalence, proudly sponsored by AstraZeneca, which has committed a generous award of $200,000 over a two-year period beginning with a Request for Proposals expected to launch in 2026.
The Urgency of Addressing Air Pollution
Recent evidence highlights a troubling correlation between air pollution and a surge in lung cancer deaths. A staggering increase of nearly 30% in lung cancer fatalities attributed to air pollution has been documented since 2007; this alarming trend surfaces as the rates of smoking decline. The International Agency for Research on Cancer (IARC) has classified outdoor air pollution, especially particulate matter (PM) smaller than 2.5 microns, as a significant cause of lung cancer. Pollutants resulting from both industrial activity and natural events like wildfires have been confirmed to elevate lung cancer risks for both smokers and non-smokers alike.
Understanding the Health Implications of Pollution
Air pollution is not merely a nuisance; it poses severe health risks and can even worsen outcomes for those already diagnosed with lung cancer. It is vital for the lung cancer community to raise awareness of air pollution as the second-largest contributing factor to lung cancer, educating patients and healthcare professionals on its impacts.
The need for a proactive approach to examining how polluted air contributes to lung cancer emergence is essential. Dr. Joan Schiller, the esteemed Founder of OUCH-International and a long-serving member of LCRF's Board of Directors, remarked, "Understanding and addressing the risks associated with air pollution is urgent. Collaborating with LCRF to offer these grants enhances our efforts to promote early detection of lung cancer. I commend AstraZeneca for supporting this crucial initiative."
Corporate Commitment to Lung Cancer Research
AstraZeneca's commitment to lung cancer research underscores the importance of addressing pollution and climate change. Nabil Chehab, who leads Medical Affairs at AstraZeneca's Lung Cancer Franchise, expressed pride in partnering with LCRF and OUCH-International, stating, "Exploring the intersection of pollution and cancer is critical. This partnership empowers the oncology community and will positively influence the education, diagnosis, and treatment journey of patients at all stages of lung cancer."
Leveraging Expertise for Better Outcomes
Through this collaboration, experts like Aubrey Rhodes, the Executive Director of LCRF, believe that enhanced understanding of environmental factors influencing lung cancer can lead to improved research findings. Rhodes emphasized that the collaboration with Dr. Schiller and her colleagues at OUCH-International will enrich the research landscape, thus paving the way for innovations in detection, diagnosis, and management of lung cancer.
About the Lung Cancer Research Foundation (LCRF)
The Lung Cancer Research Foundation (LCRF) is dedicated to funding transformative, high-impact research that promises to extend life and enhance the quality of life for patients affected by lung cancer. Over the years, LCRF has funded 431 research initiatives, amassing nearly $49 million—the largest funding amount provided by any nonprofit organization solely focused on lung cancer research. Their commitment to improving prevention, diagnosis, treatment, and ultimately, the cure for lung cancer is unwavering.
About Oncology Advocates United for Climate and Health – International (OUCH-I)
OUCH-I represents a pioneering initiative aimed at addressing the various ways climate change affects cancer care. As a non-profit and nonpartisan organization, OUCH-I focuses on promoting awareness and advocating for policies that combat the detrimental effects of climate change on cancer treatments. The group actively engages healthcare professionals from diverse backgrounds, uniting over 150 members across multiple countries to influence positive changes in cancer care delivery and increase resilience in vulnerable communities.
Contact Information
LUNG CANCER RESEARCH FOUNDATION
Sheila Sullivan
Sr. Director, Marketing & Communications
For inquiries, please contact LCRF.
OUCH – INTERNATIONAL
Joan H. Schiller, MD
For direct communication, please reach out to OUCH-I at 608-469-6992.
Frequently Asked Questions
What is the purpose of the collaboration between LCRF and OUCH-I?
The collaboration aims to study the effects of air pollution and climate change on lung cancer and fund innovative projects that address these issues.
How much funding is available for research projects?
There is a total of $200,000 available for research grants over a two-year period.
When will the Request for Proposals be open?
The Request for Proposals is expected to open in early 2026.
Why is air pollution linked to lung cancer?
Air pollution has been classified as a significant cause of lung cancer, contributing to increased mortality rates as it exacerbates risk factors for both smokers and non-smokers.
What is the mission of OUCH-I?
OUCH-I aims to mitigate the effects of climate change on cancer care through advocacy, education, and research.
